Market Place
Sourcing Support
Notice of AGM
16 Apr 2021 //
PRESS RELEASE
Mereo to Present at 20th Annual Needham Virtual Healthcare Conference
06 Apr 2021 //
PRESS RELEASE
Mereo to participate in SVB Leerink Healthcare Conference Fireside Chat
18 Feb 2021 //
PRESS RELEASE
Closing of Public Offering; Full Exercise of Over-Allotment Option
12 Feb 2021 //
PRESS RELEASE
Mereo BioPharma Group plc Announces Pricing of Public Offering of ADS
10 Feb 2021 //
PRESS RELEASE
Mereo BioPharma Group plc Announces Proposed Public Offering of ADS
09 Feb 2021 //
PRESS RELEASE
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
30 Jun 2020 //
FIERCE BIOTECH
Business Update and Directorate Change
26 Mar 2020 //
BIOSPACE
Mereo BioPharma Receives FDA Fast Track Designation for Navicixizumab
07 Oct 2019 //
YAHOO
Celgene says no to Mereo’s cancer drug etigilimab
22 Jun 2019 //
PM LIVE
Ayala`s ex-BMS drug shows promise in triple-negative breast cancer
03 Jun 2019 //
FIERCE BIOTECH
Mereo BioPharma Group Merger Update: Acquisition of OncoMed
18 Apr 2019 //
GLOBENEWSWIRE
Mereo’s shareholders back OncoMed takeover
18 Apr 2019 //
PMLIVE
Celgene ditches option to license OncoMed’s navicixizumab
18 Sep 2018 //
FIERCE BIOTECH
OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma
20 Mar 2018 //
XCONOMY
OncoMed Announces Chairman, President and Chief Ece Officer Paul J. Hastings
04 Jan 2018 //
GLOBENEWSWIRE
OncoMed Pharmaceuticals Announces Bayer Terminates
17 Jul 2017 //
GLOBENEWSWIRE
OncoMed’s Ph2 Trial of Tarextumab in Small Cell Lung Cancer Not Meet Endpoints
17 Apr 2017 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.